Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Teneurin transmembrane protein 4 (TENM4) is a large, evolutionary conserved, single-pass type II transmembrane protein predominantly expressed in the nervous system. It is a member of the teneurin family of cell adhesion molecules crucial for neural development, mediating cell-cell and synaptic interactions, and axon guidance. Structurally, TENM4 possesses domains such as EGF-like, YD repeats, and beta-propeller, contributing to its adhesive and signaling functions. TENM4 regulates neurodevelopmental processes, including synaptic partner matching and oligodendrocyte differentiation, and its loss of function is associated with defects in neuronal connectivity and hereditary essential tremor 5. In cancer, TENM4 is recurrently rearranged or fused with genes such as NRG1 to generate oncoproteins (e.g., γ-heregulin), and its expression can be epigenetically regulated. There is emerging evidence of its role in multiple cancer types, but it is not a current therapeutic drug target, nor are drugs specifically known to modulate its function[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Teneurin transmembrane protein 4 (TENM4).